Staff Oncologist and Associate Professor Hospital for Sick Children
Drug development and clinical trials in the pediatric population can present specific challenges - both real and perceived. Using examples predominantly from the pediatric oncology field, we will review these areas and how they can be addressed through careful study design and implementation.
Learning Objectives:
Participants will gain the idea of new drug development, formulation, modeling for pediatric space and potentially new evaluation, prediction method and way.
Participants will understand the movement and the whole picture of drug development from discovery, to preclinical and, potentially, clinical studies for pediatrics.
Participants will be able to build the knowledge what to expect and what will be the next wave of new drug development including clinical study for pediatrics.
Participants will understand many of the challenges (real and imagined) relating to conducting clinical trials in the pediatric setting and how these may be overcome
